Association of Serum Sclerostin Level, Coronary Artery Calcification, and Patient Outcomes in Maintenance Dialysis Patients
Author(s) -
Yifei Ge,
Buyun Wu,
Xiangbao Yu,
Ningning Wang,
Xueqiang Xu,
M. Zeng,
Bo Zhang,
Huijuan Mao,
Changying Xing
Publication year - 2021
Publication title -
blood purification
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.686
H-Index - 57
eISSN - 1421-9735
pISSN - 0253-5068
DOI - 10.1159/000516410
Subject(s) - sclerostin , medicine , agatston score , dialysis , peritoneal dialysis , hemodialysis , fibroblast growth factor 23 , prospective cohort study , gastroenterology , cardiology , urology , parathyroid hormone , coronary artery disease , biochemistry , wnt signaling pathway , chemistry , coronary artery calcium , gene , calcium
The objective of this study is to investigate the association between the serum sclerostin, the coronary artery calcification (CAC), and patient outcomes in maintenance dialysis patients.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom